Primary sarcomas and sarcoma metastases in the liver: Morphological and molecular aspects;Primäre sarkome und sarkommetastasen in der leber: Morphologische und molekulare befunde

Pathologe

Volumn 27, Issue 4, 2006, Pages 251-262

  Mechtersheimer, G ^a   Penzel, R ^a   Hofmann, W J ^b   Schirmacher, P ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Klinikum Memmingen   (Germany)

Author keywords

Immunohistochemistry; Liver; Liver metastasis; Molecular pathology; Sarcomas

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

AMELANOTIC MELANOMA; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL STROMAL TUMOR; HEMANGIOENDOTHELIOSARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KAPOSI SARCOMA; LIVER METASTASIS; NONHODGKIN LYMPHOMA; SARCOMA; SPINDLE CELL CARCINOMA; TUMOR DIFFERENTIATION;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; SARCOMA;

EID: 33745712377     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-006-0841-2     Document Type: Article

References (30)

1. Bläker H, Hofmann WJ, Theuer D, Otto HF (2001) Pathohistologische Befunde bei Lebermetastasen. Radiologe 41: 1-7
2. Blay J-Y, Bonvalot S, Casali P et al. (2005) Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST consensus conference of 20-21 March 2004, under the auspices of ESMO. Annals Oncol 16: 566-578
3. Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75: 171-190
4. Corless CL, Fletcher JA, Heinrich MC (2004) Biology of gastrointestinal stromal tumors. J Clin Oncol 22: 3813-3825
5. Corless CL, Schroeder A, Griffith D et al. (2005) PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol 23: 5357-5364
6. DeMatteo RP, Lewis JJ, Leung D et al. (2000) Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival. Ann Surg 231: 51-58
7. DeMatteo RP, Shah A, Fong Y et al. (2001) Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234: 540-548
8. El-Rifai W, Sarlomo-Rikala M, Andersson LC et al. (2000) DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance. Cancer Res 60: 3899-3903
9. Falk H, Herbert J, Crowley S et al. (1981) Epidemiology of hepatic angiosarcoma in the United States: 1964-1974. Environ Health Perspect 41: 107-113
10. Fletcher CDM, Unni KK, Mertens F (2002) World Health Organization Classification of Tumours. Pathology & genetics. Tumours of soft tissue and bone. IARC, Lyon
11. Grenacher L, Thorn M, Knaebel HP et al. (2005) Bedeutung der 3-D-Bildgebung und computerbasierten Nachverarbeitung für die Chirurgie der Leber und des Pankreas. Fortschr Röntgenstr 177: 1219-1226
12. Holloway H, Walsh CB, Thomas R, Fielding J (1996) Primary hepatic leiomyosarcoma. J Clin Gastroenterol 23: 131-133
13. Ioachim HL, Adsay V, Giancotti RF et al. (1995) Kaposi's sarcoma of internal organs. Cancer 75: 1376-1385
14. Ishak KG (1997) Malignant mesenchymal tumors and some other non-hepatocellular tumors of the liver. In: Okuda K, Tabor E (eds) Liver cancer. Churchill Livingstone, New York, pp 291-314
15. Ishak KG (2000) Liver. In: Henson DE, Albores-Saavedra J (eds) The pathology of incipient neoplasia. 3rd edn. Oxford University Press, New York
16. Ishak KG, Goodman ZD, Stocker JT (2001)Tumors of the liver and intrahepatic bile ducts. Atlas of tumor pathology, 3rd series, fascicle 31. Armed Forces Institute of Pathology, Washington/DC
17. Lehnert T, Golling M (2001) Indikationen und Ergebnisse der Lebermetastasenresektion. Radiologe 41: 40-48
18. Leuschner I, Schmidt D, Harms D (1990) Undifferentiated sarcoma of the liver in childhood: morphology, flow cytometry, and literature review. Hum Pathol 21: 68-76
19. Locker GY, Doroshow JH, Zwelling LA (1979) The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 58: 48-63
20. Maklouf HR, Ishak KG, Goodman ZD (1999) Epithelioid hemangioendothelioma of liver: a clinicopathologic study of 137 cases. Cancer 85: 999-1008
21. Medeiros F, Corless CL, Duensing A et al. (2004) KIT-negative gastrointestinal stromal tumors. Proof of concept and therapeutic implications. Am J Surg Pathol 28: 889-894
22. Miettinen M, Lindenmayer AE, Chaubal A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens - evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7: 82-90
23. Ohsawa M, Naka N, Tomita Y et al. (1995) Use of immunohistochemical procedures in diagnosing angiosarcoma. Cancer 75: 2867-2874
24. Pantanowitz L, Schwartz EJ, Dezube BJ et al. (2005) C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma. Appl Immunohistochem Mol Morphol 13: 162-166
25. Penzel R, Aulmann S, Moock M et al. (2005) The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. J Clin Pathol 58: 634-639
26. Robin Y-M, Guillou L, Michels J-J, Coindre J-M (2004) Human herpesvirus 8 immunostaining. A sensitive and specific method for diagnosing Kaposi sarcoma in paraffin-embedded sections. Am J Clin Pathol 121: 330-334
27. Selby DM, Stocker JT, Ishak KG (1992) Angiosarcoma of the liver in childhood: a clinicopathologic and follow-up study in 10 cases. Pediatr Pathol 12: 485-498
28. Verwej J, Casali PG, Zalcberg J et al. (2004) Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial. Lancet 364: 1127-1134
29. Wardelmann E, Thomas N, Merkelbach-Bruse S et al. (2005) Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations. Lancet Oncol 6: 249-251
30. Weiss SW, Goldblum JR (2001) Enzinger and Weiss's soft tissue tumors, 4th edn. Mosby, St. Louis